talazoparib,enzalutamide
pfizer,astellas
['prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'pfizer']
this year at asco #gu23, don t miss the oral presentation by on first results of a phase 3 trial of a parp inhibitor + androgen receptor inhibitor in men with metastatic castration-resistant #prostatecancer.
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ